OIAM
BNTX icon

OFI Invest Asset Management’s BioNTech BNTX Stock Holding History

OFI Invest Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,358
Closed -$533K – 275
2023
Q2 		$533K Sell
5,358
-628,514
-99% -$70.7M 0.02% 89
2023
Q1 		$5.54M Buy
+633,872
New +$87M 0.03% 95

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

OFI Invest Asset Management's BNTX Position: Q3 2023 in Review

OFI Invest Asset Management sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 5,358 shares — an estimated $533K sold.

OFI Invest Asset Management first reported a position in BNTX in Q1 2023 and held it in 2 quarters. The position peaked at $5.54M in Q1 2023. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

  • OFI Invest Asset Management reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
  • OFI Invest Asset Management sold 5,358 BioNTech shares in Q3 2023, an estimated $533K.
  • OFI Invest Asset Management first reported a position in BioNTech in Q1 2023 and held it in 2 quarters.
  • OFI Invest Asset Management's BioNTech position peaked at $5.54M in Q1 2023.
  • 252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on OFI Invest Asset Management's 13F filing for Q3 2023, filed 2 Nov 2023.